Economic Burden of Myasthenia Gravis Exacerbation and Crisis from US Payer Perspective (P9-11.034)

To evaluate the impact of myasthenia gravis (MG) diagnosis, exacerbation, and crisis on healthcare costs.

Authors

Institutions

Publication Details

Journal
Neurology
Published
2025-04-07
DOI
https://doi.org/10.1212/wnl.0000000000208741
Primary Topic
Business Strategy and Innovation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Economic Burden of Myasthenia Gravis Exacerbation and Crisis from US Payer Perspective (P9-11.034)

Maria Ait-Tihyaty, Daniel Labson, Qian Cai, Andreas Nikolaou et al.
Neurology
Business Strategy and Innovation
article

Economic Burden of Myasthenia Gravis Exacerbation and Crisis from US Payer Perspective (P9-11.034)

Maria Ait-Tihyaty, Daniel Labson, Qian Cai, Andreas Nikolaou, Kavita Gandhi, Winghan Jacqueline Kwong
article en

Abstract

To evaluate the impact of myasthenia gravis (MG) diagnosis, exacerbation, and crisis on healthcare costs.

NeurologyVol. 104(7_Supplement_1)
Global Affairs Canada (CA), Janssen (Belgium) (BE), Janssen (United States) (US)
Openalex Percentile: Top 91%
Business Strategy and Innovation
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.